PHA
Showing 26 - 50 of 230
Nutrition, Healthy Trial (fish oil)
Not yet recruiting
- Nutrition, Healthy
- fish oil
- (no location specified)
Aug 12, 2022
Influenza Trial in Rochester (FluBlok, Fluzone, FluCelVax)
Completed
- Influenza
- FluBlok
- +3 more
-
Rochester, New YorkUniversity of Rochester Medical Center, Vaccine Research Unit Ro
Nov 1, 2021
Edema Leg Trial in Oeiras (Uninterrupted motionless standing, Uninterrupted motionless sitting, Sit-to-stand transitions)
Completed
- Edema Leg
- Uninterrupted motionless standing
- +2 more
-
Oeiras, Cruz-Quebrada, PortugalFaculdade de Motricidade Humana
Jan 3, 2022
Parkinson Disease Trial (Motor-Motor Dual Task Physical Exercises)
Not yet recruiting
- Parkinson Disease
- Motor-Motor Dual Task Physical Exercises
- (no location specified)
May 30, 2023
Belatacept to Delay Tacrolimus Initiation in Kidney Transplant
Active, not recruiting
- Belatacept Impact on Patients With GDF
- impact of administering one dose of belatacept on eGFR
-
Dallas, TexasMethodist Dallas Medical Center
Oct 17, 2023
Endothelial Dysfunction, Nutritional Status, Quality of Life Trial (Non-alcoholic beer, control)
Completed
- Endothelial Dysfunction
- +2 more
- Non-alcoholic beer
- control
- (no location specified)
Aug 31, 2022
Subsequent and Co-infections Associated With SARS-CoV-2
Completed
- COVID-19
- Observational
-
Dallas, TexasMethodist Dallas Medical Center
May 24, 2022
Obese Patients Receiving Acyclovir for HSV Encephalitis
Enrolling by invitation
- HSV Encephalitis
- To assess the clinical impact of dosing acyclovir based on IBW or adjBW for HSV encephalitis to definitively guide safe and effective therapy.
-
Dallas, TexasMethodist Charlton Medical Center
Sep 12, 2022
Major Neurocognitive Disorder Trial in Montréal, Saint-Georges (GPS clinical intervention)
Recruiting
- Major Neurocognitive Disorder
- GPS clinical intervention
-
Montréal, Quebec, Canada
- +1 more
Jan 21, 2022
DiGeorge Anomaly, Complete DiGeorge Anomaly, Complete Atypical DiGeorge Anomaly Trial in Durham (biological, other, procedure,
Completed
- DiGeorge Anomaly
- +4 more
- Cultured Thymus Tissue for Implantation (CTTI)
- +8 more
-
Durham, North CarolinaDuke University Medical Center
Mar 23, 2022
Tranexamic Acid for Angiotensin-converting Enzyme
Completed
- Angioedema
-
Dallas, TexasMethodist Dallas Medical Center
Oct 17, 2023
Pharmacist-led, Collaborative Practice on Clinical Outcomes in
Active, not recruiting
- Diabetes
- Type2diabetes
- Chart Review
-
Dallas, TexasMethodist Dallas Medical Center
Aug 9, 2023
Corticosteroid Duration on SARS-CoV-2 (COVID-19 WHO)
Recruiting
- Covid 19
-
Dallas, TexasMethodist Dallas Medical Center
Oct 21, 2022
Enoxaparin in Hospitalized COVID-19 Patients
Recruiting
- Venous Thromboembolism
-
Richardson, TexasMethodist Richardson Medical Center
Oct 21, 2022
Graft Vs Host Disease, Graft-versus-host-disease, Acute Myeloid Leukemia Trial (CliniMACS® device)
Not yet recruiting
- Graft Vs Host Disease
- +5 more
- CliniMACS® device
- (no location specified)
Jul 20, 2023
Acute Upper Gastrointestinal Bleeding, Effect of Drug Trial in Bangkok (Metoclopramide, Normal Saline 10 mL Injection)
Recruiting
- Acute Upper Gastrointestinal Bleeding
- Effect of Drug
- Metoclopramide
- Normal Saline 10 mL Injection
-
Bangkok, Pathum Wan, Thailand
- +1 more
Mar 29, 2022
Cardiovascular Risk Factor, Covid19 Trial in Amman (300 mg of omega3-FA)
Completed
- Cardiovascular Risk Factor
- Covid19
- 300 mg of omega3-FA
-
Amman, JordanMahmoud S Abu-Samak
Feb 23, 2022
Guide Antibiotic Therapy Duration in the Intensive Care Unit
Enrolling by invitation
- Comparing Antibiotic Duration of Therapy
- compare antibiotic duration of therapy
-
Dallas, TexasMethodist Richardson Medical Center
Feb 23, 2023
Immune Response, Inflammation Trial (Blueberry powder group, Placebo powder group)
Not yet recruiting
- Immune Response
- Inflammation
- Blueberry powder group
- Placebo powder group
- (no location specified)
Sep 16, 2022
Evaluation of the Impact of Reduced Immunosuppression
Enrolling by invitation
- Graft Vs Host Disease
-
Dallas, TexasMethodist Dallas Medical Center
Dec 20, 2022
Immune Response Trial (MV130, Placebo)
Not yet recruiting
- Immune Response
- MV130
- Placebo
- (no location specified)
Mar 23, 2022
Chemical Venous Thromboembolism Prophylaxis in Trauma
Enrolling by invitation
- Thromboembolism, Venous
-
Dallas, TexasMethodist Dallas Medical Center Pharmacy
Sep 1, 2023
Direct Oral Anticoagulants for the Treatment of Mural Thrombus
Completed
- Acute Myocardial Infarction
-
Dallas, TexasMethodist Dallas Medical Center
Dec 9, 2021
Dehydration, Hyperhydration Trial in Lisboa (Increasing water intake)
Recruiting
- Dehydration
- Hyperhydration
- Increasing water intake
-
Lisboa, PortugalFaculdade Motricidade Humana
Jun 3, 2022
Direct Oral Anticoagulants (DOACs) in Hypercoagulable States
Completed
- Hypercoagulable States
- Observational
-
Dallas, TexasMethodist Dallas Medical Center
Dec 9, 2021